Literature DB >> 9135157

Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine.

R White1, M Sjöberg, E Kalkhoven, M G Parker.   

Abstract

The oestrogen receptor is a member of the nuclear receptor family of transcription factors which, on binding the steroid hormone 17beta-oestradiol, interacts with co-activator proteins and stimulates gene expression. Replacement of a single tyrosine in the hormone-binding domain generated activated forms of the receptor which stimulated transcription in the absence of hormone. This increased activation is related to a decrease in hydrophobicity and a reduction in size of the side chain of the amino acid with which the tyrosine is replaced. Ligand-independent, in common with ligand-dependent transcriptional activation, requires an amphipathic alpha-helix at the C-terminus of the ligand-binding domain which is essential for the interaction of the receptor with a number of potential co-activator proteins. In contrast to the wild-type protein, constitutively active receptors were able to bind both the receptor-interacting protein RIP-140 and the steroid receptor co-activator SRC-1 in a ligand-independent manner, although in the case of SRC-1 this was only evident when the receptors were prebound to DNA. We propose, therefore, that this tyrosine is required to maintain the receptor in a transcriptionally inactive state in the absence of hormone. Modification of this residue may generate a conformational change in the ligand-binding domain of the receptor to form an interacting surface which allows the recruitment of co-activators independent of hormone binding. This suggests that this tyrosine may be a target for a different signalling pathway which forms an alternative mechanism of activating oestrogen receptor-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135157      PMCID: PMC1169739          DOI: 10.1093/emboj/16.6.1427

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor.

Authors:  S E Fawell; J A Lees; R White; M G Parker
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

2.  Characterization of ligand-dependent phosphorylation of the estrogen receptor.

Authors:  H Lahooti; R White; P S Danielian; M G Parker
Journal:  Mol Endocrinol       Date:  1994-02

Review 3.  Steroid and related receptors.

Authors:  M G Parker
Journal:  Curr Opin Cell Biol       Date:  1993-06       Impact factor: 8.382

4.  Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.

Authors:  S M Aronica; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1993-06

5.  Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity.

Authors:  P Le Goff; M M Montano; D J Schodin; B S Katzenellenbogen
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

6.  Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone.

Authors:  C L Smith; O M Conneely; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.

Authors:  B D'Souza; F Berdichevsky; N Kyprianou; J Taylor-Papadimitriou
Journal:  Oncogene       Date:  1993-07       Impact factor: 9.867

8.  Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues.

Authors:  C Rochette-Egly; M P Gaub; Y Lutz; S Ali; I Scheuer; P Chambon
Journal:  Mol Endocrinol       Date:  1992-12

9.  Environmentally persistent alkylphenolic compounds are estrogenic.

Authors:  R White; S Jobling; S A Hoare; J P Sumpter; M G Parker
Journal:  Endocrinology       Date:  1994-07       Impact factor: 4.736

10.  Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor.

Authors:  D Barettino; M M Vivanco Ruiz; H G Stunnenberg
Journal:  EMBO J       Date:  1994-07-01       Impact factor: 11.598

View more
  26 in total

1.  A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.

Authors:  V Vivat; C Zechel; J M Wurtz; W Bourguet; H Kagechika; H Umemiya; K Shudo; D Moras; H Gronemeyer; P Chambon
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

2.  Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor.

Authors:  Akiko Koide; Stacy Abbatiello; Lisa Rothgery; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

3.  Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.

Authors:  D Chen; P E Pace; R C Coombes; S Ali
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  Heat shock protein 90 and the nuclear transport of progesterone receptor.

Authors:  M Haverinen; S Passinen; H Syvälä; S Pasanen; T Manninen; P Tuohimaa; T Ylikomi
Journal:  Cell Stress Chaperones       Date:  2001-07       Impact factor: 3.667

5.  Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer.

Authors:  Rinath Jeselsohn; Roman Yelensky; Gilles Buchwalter; Garrett Frampton; Funda Meric-Bernstam; Ana Maria Gonzalez-Angulo; Jaime Ferrer-Lozano; Jose A Perez-Fidalgo; Massimo Cristofanilli; Henry Gómez; Carlos L Arteaga; Jennifer Giltnane; Justin M Balko; Maureen T Cronin; Mirna Jarosz; James Sun; Matthew Hawryluk; Doron Lipson; Geoff Otto; Jeffrey S Ross; Addie Dvir; Lior Soussan-Gutman; Ido Wolf; Tamar Rubinek; Lauren Gilmore; Stuart Schnitt; Steven E Come; Lajos Pusztai; Philip Stephens; Myles Brown; Vincent A Miller
Journal:  Clin Cancer Res       Date:  2014-01-07       Impact factor: 12.531

Review 6.  Estrogen receptor interaction with estrogen response elements.

Authors:  C M Klinge
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

7.  Activation of androgen receptor function by a novel nuclear protein kinase.

Authors:  A M Moilanen; U Karvonen; H Poukka; O A Jänne; J J Palvimo
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

Review 8.  Estrogen receptor alpha in human breast cancer: occurrence and significance.

Authors:  S Ali; R C Coombes
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

9.  Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1.

Authors:  R M Zwijsen; R S Buckle; E M Hijmans; C J Loomans; R Bernards
Journal:  Genes Dev       Date:  1998-11-15       Impact factor: 11.361

10.  Characterization of the DNA-binding and dimerization properties of the nuclear orphan receptor germ cell nuclear factor.

Authors:  H Greschik; J M Wurtz; P Hublitz; F Köhler; D Moras; R Schüle
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.